Market Pulse: Pure ROI is MIA in Corporate CRM Assessments - Pharmaceutical Executive

ADVERTISEMENT

Market Pulse: Pure ROI is MIA in Corporate CRM Assessments


Pharmaceutical Executive

Direct marketing company Harte-Hanks surveyed 464 North American companies involved in manufacturing, wholesale/retail, services, finance/insurance/real estate, and transportation/utilities and found that many (44 percent) don't use pure return on investment (ROI) to evaluate their customer relationship management (CRM) systems. Instead, they commonly con-sider some customer-centric metrics that contribute to the venture's overall success.

The survey identifies IT departments and managers as the main decision makers in CRM implementation-52 percent say IT manages their CRM development and main-tenance budgets-although senior managers are gaining in budget responsibility among companies planning CRM initiatives within the next 12 months. Nearly 80 percent report that they treat CRM development and imple-mentation as a corporate initiative and not as a depart-ment-specific project.

According to the report, the main requirement of a CRM system is to offer users a "clean and complete profile of clients and prospects." Sixty-eight percent say they want to see the connections between specific marketing programs and revenue streams from specific clients. Only 19 percent report the need for a client's product-purchase history, a finding that might have been very different if pharma companies had been singled out for the research.

ADVERTISEMENT

blog comments powered by Disqus
UPCOMING CONFERENCES

Serialization Summit
San Diego, CA
Feb. 27-28, 2014



Advances in Aseptic Processing
San Diego, CA
Mar. 10-12, 2014



ClinTech 2014
Cambridge, MA
Mar. 11-13 2014


Investigator-Initiated and
Sponsored Research (IISR)

Philadelphia, PA
Mar. 19-20 2014

See All Conferences >>


Click here